
Clinical outcomes of ultrathin biodegradable polymer-coated sirolimus-eluting stents in an all-comer population: One-year results from the T-FLEX registry including high-risk subgroups
Author(s) -
Ramesh Babu Pothineni,
Vikrant Vijan,
Anil Potdar,
Manohar Inamdar,
Abhijit Pathak,
Sai Sudhakar Mantravadi,
Prakash Ajmera
Publication year - 2021
Publication title -
pubmed central
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.364
H-Index - 28
eISSN - 2149-2271
DOI - 10.5152/anatoljcardiol.2021.78291
Subject(s) - medicine , target lesion , myocardial infarction , clinical endpoint , stent , population , confidence interval , surgery , drug eluting stent , incidence (geometry) , hazard ratio , acute coronary syndrome , clinical trial , percutaneous coronary intervention , environmental health , physics , optics
T-Flex registry was designed to investigate the safety and clinical performance of the ultrathin (60 µm) strut biodegradable polymer-coated sirolimus-eluting stent (SES) with a unique long dual Z (LDZ) link design on a cobalt-chromium stent platform (Sahajanand Medical Technologies Pvt. Ltd., Surat, India) in a real-world all-comer population including high-risk subgroups.